CVS
CVS Health Corp
NYSE: CVS · HEALTHCARE · HEALTHCARE PLANS
$82.01
-0.10% today
Updated 2026-05-04
Market cap
$105.21B
P/E ratio
59.06
P/S ratio
0.26x
EPS (TTM)
$1.39
Dividend yield
3.19%
52W range
$56 – $84
Volume
7.7M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.0
Quality
C+4.0
Profitability
C7.3
Valuation
B+4/9
Piotroski F-Score
Moderate
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$96.58
+17.77%
12-Month target
$42.02
-48.76%
Intrinsic (DCF)
$340.13
Margin of safety
+77.36%
7 Strong Buy18 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $2.61B — positive
+ 77.36% below intrinsic value
Risks
- Thin margins at 0.44%
- P/E 59.06x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $322.47B | $357.78B | $372.81B | $402.07B | $399.83B | $409.6B |
| Net income | $4.31B | $8.34B | $4.61B | $1.77B | $2.94B | — |
| EPS | — | — | — | — | $1.39 | $7.25 |
| Free cash flow | $13.45B | $10.39B | $6.33B | $7.81B | $2.61B | — |
| Profit margin | 1.34% | 2.33% | 1.24% | 0.44% | 0.44% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | SHAH, PREM S | Sale | 1,484 | $72.49 |
| 2026-04-01 | NELSON, STEVEN H | Sale | 2,432 | $72.49 |
| 2026-04-01 | MANDADI, TILAK | Sale | 3,634 | $72.49 |
Peer comparison
Smart narrative
CVS Health Corp trades at $82.01. representing a P/E of 59.06x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.11, it sits in the grey zone. TTM revenue stands at $399.83B. with profit margins at 0.44%. Our DCF model estimates intrinsic value at $340.13.
Frequently asked questions
What is CVS Health Corp's stock price?
CVS Health Corp (CVS) trades at $82.01.
Is CVS Health Corp overvalued?
Smart Value Score 65/100 (Grade B, Buy). DCF value $340.13.
What is the price target of CVS Health Corp (CVS)?
The analyst target price is $96.58, representing +17.8% upside from the current price of $82.01.
What is the intrinsic value of CVS Health Corp (CVS)?
Based on our DCF model, intrinsic value is $340.13, a +77.4% margin of safety versus $82.01.
What is the future stock price of CVS by 2030?
Our research-backed model estimates CVS Health Corp could reach $4,681.31 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is CVS Health Corp's revenue?
TTM revenue is $399.83B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.11 — grey zone.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.26x
ROE2.29%
Beta0.51
50D MA$76.51
200D MA$75.60
Shares out1.28B
Float1.27B
Short ratio—
Avg volume7.7M
Performance
1 week-2.25%
1 month+11.91%
3 months+9.00%
YTD+3.34%
1 year—
3 years—
5 years—